Comparison of the 4 genetic groups in terms of EFS and survival: 3-year estimate rates and the hazard ratio estimates by taking other as the baseline group
. | HOX11L2-positive, N = 35 . | HOX11-high, N = 10 . | SIL-TAL, N = 17 . | Other,*N = 76 . |
|---|---|---|---|---|
| EFS | ||||
| 3-year rate, % (SE %) | 75.5 (8.1) | 83.3 (8.5) | 75.3 (12.6) | 65.1 (6.4) |
| Hazard ratio (95% CI) | 0.75 (0.34-1.66) | 0.29 (0.04-2.16) | 0.63 (0.19-2.11) | 1 |
| Survival | ||||
| 3-year rate, % (SE %) | 77.3 (8.4) | 100 (0) | 94.1 (3.0) | 67.4 (6.3) |
| Hazard ratio (95% CI) | 0.62 (0.26-1.46) | —† | 0.21 (0.03-1.56) | 1 |
. | HOX11L2-positive, N = 35 . | HOX11-high, N = 10 . | SIL-TAL, N = 17 . | Other,*N = 76 . |
|---|---|---|---|---|
| EFS | ||||
| 3-year rate, % (SE %) | 75.5 (8.1) | 83.3 (8.5) | 75.3 (12.6) | 65.1 (6.4) |
| Hazard ratio (95% CI) | 0.75 (0.34-1.66) | 0.29 (0.04-2.16) | 0.63 (0.19-2.11) | 1 |
| Survival | ||||
| 3-year rate, % (SE %) | 77.3 (8.4) | 100 (0) | 94.1 (3.0) | 67.4 (6.3) |
| Hazard ratio (95% CI) | 0.62 (0.26-1.46) | —† | 0.21 (0.03-1.56) | 1 |